Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.29 trillion and total revenue of $114.73 billion.
Market Cap
1.29T
Revenue
114.73B
Profits
-40.53B
PE Ratio
n/a
Profit Margin
-35.32%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 125.73B | 2.49% | 992,491 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.32B | 1.59% | 837,598 | 15.53B |
| 3 | ARGX | argenx SE | 55.18B | -1.17% | 250,019 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 43.97B | 3.71% | 1,665,276 | - |
| 5 | ONC | BeOne Medicines AG | 39.60B | 5.60% | 638,196 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 32.64B | -0.86% | 4,159,406 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.33B | 1.43% | 1,735,992 | 4.80B |
| 8 | INSM | Insmed Incorporated | 28.63B | -1.09% | 4,904,625 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.25B | 3.47% | 6,743,447 | 7.53M |
| 10 | INCY | Incyte Corporation | 24.44B | 1.84% | 1,540,374 | 5.82B |
| 11 | MRNA | Moderna, Inc. | 23.62B | 9.86% | 6,820,581 | 2.23B |
| 12 | BNTX | BioNTech SE | 23.53B | 2.72% | 1,427,942 | 3.03B |
| 13 | GMAB | Genmab A/S | 18.45B | 4.76% | 3,507,362 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.84B | 2.23% | 325,562 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.65B | -0.04% | 970,711 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.51B | 2.03% | 2,148,202 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.40B | 3.58% | 3,550,013 | 2.44B |
| 18 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.38B | 2.12% | 948,275 | 669.50M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.35B | 3.82% | 4,365,210 | 3.41B |
| 20 | CORT | Corcept Therapeutics Incorporated | 11.97B | 2.61% | 769,043 | 830.81M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.78B | -0.06% | 347,529 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 11.70B | 20.24% | 7,691,626 | 1.66B |
| 23 | ABVX | ABIVAX Société Anonyme | 11.37B | 0.72% | 1,100,268 | 5.67M |
| 24 | TECH | Bio-Techne Corporation | 11.26B | 0.54% | 5,577,383 | 1.21B |
| 25 | SMMT | Summit Therapeutics Inc. | 11.14B | 3.10% | 2,182,584 | - |
| 26 | AXSM | Axsome Therapeutics, Inc. | 10.95B | 1.24% | 1,024,526 | 708.24M |
| 27 | CYTK | Cytokinetics, Incorporated | 10.67B | -5.67% | 3,604,464 | 67.67M |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.12B | 0.26% | 1,495,197 | - |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 10.07B | -2.54% | 454,895 | 7.46M |
| 30 | KRYS | Krystal Biotech, Inc. | 9.66B | 1.17% | 160,038 | 440.48M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.44B | -0.21% | 321,085 | 281.99M |
| 32 | IONS | Ionis Pharmaceuticals, Inc. | 9.40B | 3.80% | 2,009,277 | 874.09M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 9.25B | 1.44% | 526,596 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 8.94B | 1.04% | 463,575 | 105.00M |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.92B | 0.19% | 1,941,777 | 42.16M |
| 36 | PCVX | Vaxcyte, Inc. | 8.64B | -1.39% | 1,296,254 | - |
| 37 | IMVT | Immunovant, Inc. | 8.25B | 0.53% | 906,297 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.10B | 4.37% | 9,391,477 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.96B | 3.15% | 672,761 | 239.92M |
| 40 | COGT | Cogent Biosciences, Inc. | 7.24B | 1.41% | 1,855,798 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 7.06B | 0.42% | 1,768,460 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.66B | 0.33% | 611,588 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.54B | 6.94% | 850,714 | 618.07M |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.44B | 0.53% | 958,437 | - |
| 45 | CAI | Caris Life Sciences, Inc. | 6.43B | 13.70% | 9,401,862 | 989.61M |
| 46 | BLTE | Belite Bio, Inc | 6.41B | 1.48% | 126,436 | - |
| 47 | ERAS | Erasca, Inc. | 6.39B | 0.77% | 2,096,111 | - |
| 48 | DFTX | Definium Therapeutics, Inc. | 6.20B | - | 2,547,272 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 6.14B | -1.84% | 720,238 | 7.50M |
| 50 | PTCT | PTC Therapeutics, Inc. | 6.12B | 3.47% | 963,179 | 1.01B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 6.09B | -0.91% | 570,471 | 1.90M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.96B | 0.41% | 308,667 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 5.81B | -2.33% | 313,612 | 290.54M |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.78B | -1.81% | 1,226,692 | 591.33M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.17B | 3.64% | 1,284,025 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.03B | 2.67% | 1,782,723 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.90B | 1.43% | 1,991,002 | - |
| 58 | MANE | Veradermics, Incorporated | 4.78B | 5.28% | 542,268 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.73B | -2.03% | 1,478,271 | - |
| 60 | CELC | Celcuity Inc. | 4.52B | -0.50% | 543,220 | - |
| 61 | PBLS | Parabilis Medicines, Inc. | 4.45B | -1.69% | 279,895 | - |
| 62 | ELVN | Enliven Therapeutics, Inc. | 4.43B | 0.32% | 696,068 | - |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.33B | 0.10% | 2,315,219 | 10.35M |
| 64 | LEGN | Legend Biotech Corporation | 4.01B | 7.62% | 2,611,227 | 1.14B |
| 65 | VKTX | Viking Therapeutics, Inc. | 4.00B | 2.88% | 1,402,492 | - |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.99B | 8.27% | 212,702 | 803.79M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.94B | 0.40% | 1,750,014 | 3.60M |
| 68 | TNGX | Tango Therapeutics, Inc. | 3.92B | -6.66% | 3,231,244 | 56.99M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.78B | 0.99% | 329,496 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.64B | 1.02% | 1,061,512 | 117.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.57B | 2.15% | 602,342 | 234.13M |
| 72 | ALMS | Alumis Inc. | 3.52B | -0.72% | 843,458 | 8.40M |
| 73 | NAMS | NewAmsterdam Pharma Company N.V. | 3.34B | 1.05% | 572,011 | 7.12M |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.28B | 0.36% | 808,913 | 158.00K |
| 75 | MBX | MBX Biosciences, Inc. | 3.27B | 1.06% | 545,508 | - |
| 76 | QURE | uniQure N.V. | 3.22B | 2.34% | 1,827,865 | 18.67M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 3.18B | -4.31% | 2,449,133 | 463.98M |
| 78 | IRON | Disc Medicine, Inc. | 2.97B | - | 307,550 | - |
| 79 | IOVA | Iovance Biotherapeutics, Inc. | 2.87B | 2.09% | 30,970,677 | 324.97M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.84B | -0.83% | 983,151 | 606.33M |
| 81 | IMNM | Immunome, Inc. | 2.83B | -3.06% | 881,140 | 4.02M |
| 82 | KOD | Kodiak Sciences Inc. | 2.83B | -0.07% | 511,438 | - |
| 83 | BEAM | Beam Therapeutics Inc. | 2.75B | 0.84% | 1,324,280 | 156.04M |
| 84 | ATAI | AtaiBeckley Inc. | 2.68B | 0.97% | 6,408,593 | 3.49M |
| 85 | VRDN | Viridian Therapeutics, Inc. | 2.67B | 4.80% | 1,659,872 | 71.13M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.65B | 1.23% | 729,851 | 36.77M |
| 87 | TRVI | Trevi Therapeutics, Inc. | 2.64B | 0.05% | 2,194,695 | - |
| 88 | ZLAB | Zai Lab Limited | 2.62B | 11.69% | 2,046,150 | 449.61M |
| 89 | PGEN | Precigen, Inc. | 2.59B | 4.63% | 5,758,900 | 85.72M |
| 90 | NKTR | Nektar Therapeutics | 2.58B | 4.13% | 899,158 | 55.63M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.55B | 0.35% | 3,829,203 | 717.00M |
| 92 | PHVS | Pharvaris N.V. | 2.44B | 1.34% | 696,389 | - |
| 93 | KLRA | Kailera Therapeutics, Inc. | 2.42B | -1.11% | 276,243 | - |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 1.33% | 386,167 | - |
| 95 | SLS | SELLAS Life Sciences Group, Inc. | 2.36B | 2.65% | 5,124,095 | - |
| 96 | VERA | Vera Therapeutics, Inc. | 2.36B | 2.72% | 1,515,230 | - |
| 97 | COAG | Hemab Therapeutics Holdings, Inc. | 2.32B | -4.79% | 415,713 | - |
| 98 | NUVB | Nuvation Bio Inc. | 2.32B | 8.02% | 5,777,359 | 169.90M |
| 99 | VCEL | Vericel Corporation | 2.31B | 0.76% | 472,912 | 306.30M |
| 100 | SION | Sionna Therapeutics, Inc. | 2.31B | 2.88% | 747,528 | - |
| 101 | URGN | UroGen Pharma Ltd. | 2.30B | 2.98% | 1,026,475 | 188.73M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.27B | 1.83% | 182,301 | - |
| 103 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | -0.88% | 994,523 | 959.90M |
| 104 | ADMA | ADMA Biologics, Inc. | 2.22B | -1.59% | 3,305,415 | 512.28M |
| 105 | BHVN | Biohaven Ltd. | 2.21B | 1.66% | 1,121,821 | - |
| 106 | RAPP | Rapport Therapeutics, Inc. | 2.18B | -1.86% | 246,056 | 20.00M |
| 107 | ABCL | AbCellera Biologics Inc. | 2.12B | 6.13% | 6,823,455 | 66.17M |
| 108 | STOK | Stoke Therapeutics, Inc. | 2.11B | 2.44% | 866,579 | 27.59M |
| 109 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -1.74% | 1,545,230 | 311.51M |
| 110 | TSHA | Taysha Gene Therapies, Inc. | 2.10B | 3.47% | 1,929,729 | 7.47M |
| 111 | GHRS | GH Research PLC | 2.08B | -1.21% | 337,192 | - |
| 112 | MESO | Mesoblast Limited | 2.05B | 2.05% | 80,930 | 65.38M |
| 113 | ZBIO | Zenas BioPharma, Inc. | 2.05B | 0.81% | 264,068 | 10.00M |
| 114 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 5.15% | 2,016,650 | 52.06M |
| 115 | NBTX | Nanobiotix S.A. | 1.96B | 1.14% | 107,384 | 38.27M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | 1.00% | 1,399,667 | 98.34M |
| 117 | BRVE | Braveheart Bio, Inc. | 1.93B | 0.67% | 566,967 | - |
| 118 | FBRX | Forte Biosciences, Inc. | 1.88B | -0.05% | 1,163,855 | - |
| 119 | BCAX | Bicara Therapeutics Inc. | 1.84B | 2.00% | 570,569 | - |
| 120 | GENB | Generate Biomedicines, Inc. | 1.84B | 3.31% | 505,960 | 26.48M |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.84B | 0.13% | 197,365 | - |
| 122 | KARD | Kardigan, Inc. | 1.83B | 0.69% | 160,054 | - |
| 123 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | 3.24% | 1,247,680 | 252.25M |
| 124 | LKFT | Lakefront Biotherapeutics NV | 1.78B | 3.33% | 139,063 | 1.20B |
| 125 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | - | 3,064,146 | 1.97B |
| 126 | FTRE | Fortrea Holdings Inc. | 1.75B | 4.18% | 989,729 | 2.68B |
| 127 | SEPN | Septerna, Inc. | 1.75B | -1.77% | 303,804 | 72.26M |
| 128 | IMCR | Immunocore Holdings plc | 1.73B | -1.45% | 492,086 | 430.78M |
| 129 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | 1.26% | 9,355,890 | 54.86M |
| 130 | AAPG | Ascentage Pharma Group International | 1.71B | 11.09% | 8,680 | 82.08M |
| 131 | ANAB | AnaptysBio, Inc. | 1.68B | 3.36% | 546,728 | 232.39M |
| 132 | NTLA | Intellia Therapeutics, Inc. | 1.67B | 6.23% | 4,937,182 | 59.51M |
| 133 | ZYME | Zymeworks Inc. | 1.67B | 1.77% | 578,107 | 37.13M |
| 134 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.62B | -0.32% | 4,077,591 | 208.78M |
| 135 | MAZE | Maze Therapeutics, Inc. | 1.59B | 0.42% | 480,730 | 20.00M |
| 136 | TYRA | Tyra Biosciences, Inc. | 1.58B | -1.67% | 820,624 | - |
| 137 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | 0.04% | 629,380 | - |
| 138 | XNCR | Xencor, Inc. | 1.55B | 4.05% | 1,124,578 | 104.97M |
| 139 | ABSI | Absci Corporation | 1.51B | 7.59% | 2,193,536 | 1.84M |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.51B | 1.28% | 902,063 | - |
| 141 | AVLN | Avalyn Pharma Inc. | 1.50B | 3.73% | 120,915 | - |
| 142 | VIR | Vir Biotechnology, Inc. | 1.49B | 0.57% | 1,663,130 | 303.23M |
| 143 | INVA | Innoviva, Inc. | 1.48B | -2.84% | 1,143,291 | 440.00M |
| 144 | SVRA | Savara Inc. | 1.48B | 0.69% | 1,586,205 | - |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.44B | -0.55% | 302,089 | - |
| 146 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | 4.41% | 1,330,663 | - |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.38B | -0.37% | 269,180 | - |
| 148 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | 1.08% | 1,031,392 | 28.73M |
| 149 | AKTS | Aktis Oncology, Inc. | 1.33B | 2.94% | 154,844 | 8.28M |
| 150 | MNKD | MannKind Corporation | 1.32B | 5.66% | 5,048,122 | 393.63M |
| 151 | IMTX | Immatics N.V. | 1.32B | 2.44% | 309,304 | 43.00M |
| 152 | NVAX | Novavax, Inc. | 1.31B | 2.71% | 5,704,173 | 413.80M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.30B | -1.26% | 481,234 | - |
| 154 | INBX | Inhibrx Biosciences, Inc. | 1.30B | 3.35% | 407,686 | 1.30M |
| 155 | VOR | Vor Biopharma Inc. | 1.28B | -0.13% | 801,804 | - |
| 156 | SPTX | Seaport Therapeutics, Inc. | 1.26B | 2.30% | 112,372 | - |
| 157 | MGTX | MeiraGTx Holdings plc | 1.21B | 2.19% | 392,264 | 79.76M |
| 158 | WVE | Wave Life Sciences Ltd. | 1.20B | 1.33% | 4,556,373 | 65.37M |
| 159 | EYPT | EyePoint, Inc. | 1.20B | 8.26% | 1,655,697 | 2.79M |
| 160 | OBX | Obsidian Therapeutics, Inc. | 1.19B | -3.00% | 8,857 | - |
| 161 | DRTS | Alpha Tau Medical Ltd. | 1.19B | 1.15% | 297,026 | - |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | 0.43% | 1,370,052 | - |
| 163 | IVA | Inventiva S.A. | 1.16B | 3.00% | 579,072 | 7.94M |
| 164 | LTGO | Latigo Biotherapeutics, Inc. | 1.15B | 1.39% | 3,303,862 | - |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 1.14B | -1.23% | 361,755 | - |
| 166 | ANRO | Alto Neuroscience, Inc. | 1.11B | 0.70% | 336,435 | - |
| 167 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.10B | 4.66% | 3,085,742 | 41.47M |
| 168 | APMD | Apnimed, Inc. | 1.08B | -3.16% | 160,891 | 120.15M |
| 169 | SANA | Sana Biotechnology, Inc. | 1.06B | 3.23% | 2,153,477 | - |
| 170 | OLMA | Olema Pharmaceuticals, Inc. | 1.05B | 2.12% | 757,198 | - |
| 171 | ODTX | Odyssey Therapeutics, Inc. | 1.01B | -1.76% | 97,818 | 99.00K |
| 172 | REPL | Replimune Group, Inc. | 1.01B | -6.22% | 8,914,082 | - |
| 173 | ARDX | Ardelyx, Inc. | 996.75M | -17.86% | 20,071,167 | 450.89M |
| 174 | AVTX | Avalo Therapeutics, Inc. | 982.50M | -2.03% | 730,255 | 59.00K |
| 175 | JANX | Janux Therapeutics, Inc. | 969.02M | -1.55% | 689,025 | 24.00M |
| 176 | OMER | Omeros Corporation | 958.97M | 0.76% | 1,227,716 | 9.89M |
| 177 | GERN | Geron Corporation | 950.86M | -5.73% | 8,885,551 | 204.56M |
| 178 | ABUS | Arbutus Biopharma Corporation | 914.60M | 1.98% | 796,105 | 191.45M |
| 179 | SLDB | Solid Biosciences Inc. | 899.62M | -3.67% | 1,054,939 | - |
| 180 | ANNX | Annexon, Inc. | 886.39M | -3.39% | 2,045,961 | - |
| 181 | AURA | Aura Biosciences, Inc. | 881.29M | 3.50% | 538,278 | - |
| 182 | TBPH | Theravance Biopharma, Inc. | 877.45M | 0.06% | 2,722,743 | 109.78M |
| 183 | DSGN | Design Therapeutics, Inc. | 875.52M | 1.60% | 418,867 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 869.95M | -2.96% | 2,388,050 | 8.22M |
| 185 | ATTO | Attovia Therapeutics, Inc. | 867.90M | -1.03% | 237,911 | 1.35M |
| 186 | KURA | Kura Oncology, Inc. | 849.57M | 3.13% | 749,269 | 71.64M |
| 187 | SGP | SpyGlass Pharma, Inc. | 846.57M | 2.26% | 72,034 | - |
| 188 | CLYM | Climb Bio, Inc. | 804.11M | - | 910,275 | - |
| 189 | MNPR | Monopar Therapeutics Inc. | 798.56M | -0.83% | 223,299 | - |
| 190 | DBVT | DBV Technologies S.A. | 795.72M | -1.89% | 698,714 | 5.04M |
| 191 | PHAR | Pharming Group N.V. | 785.51M | 0.92% | 6,392 | 366.48M |
| 192 | OCS | Oculis Holding AG | 782.76M | 2.42% | 370,878 | 1.45M |
| 193 | DRUG | Bright Minds Biosciences Inc. | 781.58M | -1.82% | 156,405 | - |
| 194 | CADL | Candel Therapeutics, Inc. | 775.93M | 0.09% | 800,789 | - |
| 195 | TENX | Tenax Therapeutics, Inc. | 769.87M | 0.98% | 2,094,837 | - |
| 196 | CTMX | CytomX Therapeutics, Inc. | 753.93M | 2.67% | 2,461,730 | 18.30M |
| 197 | RIGL | Rigel Pharmaceuticals, Inc. | 750.37M | 2.42% | 315,510 | 276.79M |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 747.40M | 6.26% | 219,414 | - |
| 199 | CBIO | Crescent Biopharma, Inc. | 720.77M | 2.50% | 150,669 | 11.88M |
| 200 | HELP | Cybin Inc. | 719.64M | 4.59% | 1,739,908 | - |
| 201 | AGMB | AgomAb Therapeutics NV | 714.10M | 7.41% | 367,401 | - |
| 202 | NGNE | Neurogene Inc. | 711.19M | 0.25% | 103,222 | 925.00K |
| 203 | RGNX | REGENXBIO Inc. | 707.66M | -4.96% | 1,387,935 | 174.48M |
| 204 | GYRE | Gyre Therapeutics, Inc. | 707.25M | 4.22% | 68,093 | 109.82M |
| 205 | IMMX | Immix Biopharma, Inc. | 695.36M | -3.38% | 1,604,784 | - |
| 206 | ALLO | Allogene Therapeutics, Inc. | 693.76M | 2.03% | 3,699,202 | 22.00K |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 686.48M | -2.69% | 1,262,935 | 136.07M |
| 208 | ACHV | Achieve Life Sciences, Inc. | 682.68M | 1.53% | 712,556 | - |
| 209 | PHAT | Phathom Pharmaceuticals, Inc. | 679.13M | 1.91% | 2,311,293 | 239.66M |
| 210 | MDXG | MiMedx Group, Inc. | 632.60M | 3.83% | 1,361,862 | 355.17M |
| 211 | FTH | Faeth Therapeutics, Inc. | 628.74M | -0.37% | 202,840 | - |
| 212 | NVCT | Nuvectis Pharma, Inc. | 617.42M | 0.64% | 171,971 | - |
| 213 | SPRY | ARS Pharmaceuticals, Inc. | 611.71M | 10.99% | 2,155,796 | 98.99M |
| 214 | VSTM | Verastem, Inc. | 610.40M | 14.04% | 4,319,009 | 87.53M |
| 215 | TECX | Tectonic Therapeutic, Inc. | 605.64M | 2.51% | 271,645 | - |
| 216 | ALT | Altimmune, Inc. | 598.98M | 2.33% | 4,506,100 | 36.00K |
| 217 | CRMD | CorMedix Inc. | 583.68M | -0.93% | 740,967 | 400.05M |
| 218 | ARVN | Arvinas, Inc. | 572.13M | 0.81% | 1,218,176 | 316.70M |
| 219 | ZURA | Zura Bio Limited | 566.66M | 4.47% | 955,899 | - |
| 220 | CTNM | Contineum Therapeutics, Inc. | 565.82M | -2.02% | 528,933 | - |
| 221 | SLN | Silence Therapeutics plc | 564.45M | 1.96% | 316,886 | 839.00K |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 561.97M | 1.90% | 346,898 | 88.24M |
| 223 | AUTL | Autolus Therapeutics plc | 561.56M | 5.50% | 2,035,647 | 92.62M |
| 224 | SGMT | Sagimet Biosciences Inc. | 559.47M | 3.66% | 1,113,093 | - |
| 225 | STTK | Shattuck Labs, Inc. | 557.47M | 1.54% | 894,453 | 1.00M |
| 226 | MPLT | MapLight Therapeutics, Inc. | 551.86M | -8.36% | 432,840 | - |
| 227 | ARTV | Artiva Biotherapeutics, Inc. | 550.99M | -2.68% | 214,691 | 251.00K |
| 228 | PRME | Prime Medicine, Inc. | 547.95M | 4.41% | 1,976,941 | 4.07M |
| 229 | DNA | Ginkgo Bioworks Holdings, Inc. | 536.70M | -6.24% | 1,653,600 | 132.42M |
| 230 | ANL | Adlai Nortye Ltd. | 531.20M | -4.05% | 270,001 | 5.00M |
| 231 | RLMD | Relmada Therapeutics, Inc. | 526.95M | -8.01% | 2,125,224 | - |
| 232 | ASMB | Assembly Biosciences, Inc. | 513.62M | 0.87% | 119,772 | 71.10M |
| 233 | EVMN | Evommune, Inc. | 510.99M | 5.23% | 374,013 | 10.00M |
| 234 | EIKN | Eikon Therapeutics, Inc. | 502.95M | 0.87% | 662,655 | - |
| 235 | ENTX | Entera Bio Ltd. | 496.92M | 1.77% | 244,946 | 42.00K |
| 236 | VALN | Valneva SE | 496.81M | 2.32% | 44,235 | 180.25M |
| 237 | PROK | ProKidney Corp. | 495.38M | - | 739,102 | 889.00K |
| 238 | OVID | Ovid Therapeutics Inc. | 490.86M | -0.75% | 919,698 | 7.12M |
| 239 | SCTX | Scribe Therapeutics Inc. | 490.47M | 2.32% | 120,181 | 36.28M |
| 240 | BLSM | BlossomHill Therapeutics, Inc. | 490.30M | - | 1,757,634 | - |
| 241 | RZLT | Rezolute, Inc. | 489.95M | -0.21% | 986,261 | - |
| 242 | PRLD | Prelude Therapeutics Incorporated | 485.97M | 4.70% | 165,697 | 16.72M |
| 243 | KYTX | Kyverna Therapeutics, Inc. | 483.93M | 2.71% | 431,849 | - |
| 244 | IKT | Inhibikase Therapeutics, Inc. | 482.69M | 2.49% | 386,846 | 1.00 |
| 245 | BNTC | Benitec Biopharma Inc. | 468.25M | 3.81% | 41,160 | - |
| 246 | QTTB | Q32 Bio Inc. | 464.40M | -3.70% | 513,474 | 53.74M |
| 247 | XFOR | X4 Pharmaceuticals, Inc. | 460.04M | 11.27% | 1,597,331 | 15.85M |
| 248 | PBYI | Puma Biotechnology, Inc. | 459.93M | 9.73% | 683,333 | 231.24M |
| 249 | CABA | Cabaletta Bio, Inc. | 454.92M | 1.09% | 2,697,659 | - |
| 250 | PRTA | Prothena Corporation plc | 449.71M | 2.10% | 481,885 | 54.53M |
| 251 | OABI | OmniAb, Inc. | 447.80M | 37.50% | 2,681,408 | 38.46M |
| 252 | EPRX | Eupraxia Pharmaceuticals Inc. | 443.40M | 1.65% | 475,865 | - |
| 253 | EDIT | Editas Medicine, Inc. | 442.31M | -0.69% | 1,692,930 | 47.01M |
| 254 | VTVT | vTv Therapeutics Inc. | 438.92M | 2.20% | 147,518 | 36.84M |
| 255 | LRMR | Larimar Therapeutics, Inc. | 434.23M | -0.95% | 631,188 | - |
| 256 | OCGN | Ocugen, Inc. | 434.06M | 3.23% | 4,537,423 | 4.58M |
| 257 | SLBT | SL Science Holding Limited | 431.54M | -2.20% | 26,439 | 3.27M |
| 258 | STRO | Sutro Biopharma, Inc. | 420.56M | 5.09% | 169,450 | 99.61M |
| 259 | AVIR | Atea Pharmaceuticals, Inc. | 420.14M | 5.21% | 264,994 | - |
| 260 | ABEO | Abeona Therapeutics Inc. | 412.64M | 4.93% | 1,396,871 | 14.54M |
| 261 | CCCC | C4 Therapeutics, Inc. | 412.42M | 2.47% | 1,504,082 | 34.86M |
| 262 | FENC | Fennec Pharmaceuticals Inc. | 402.08M | 6.78% | 226,653 | 51.00M |
| 263 | ENTA | Enanta Pharmaceuticals, Inc. | 400.41M | 3.22% | 182,991 | 69.21M |
| 264 | UPB | Upstream Bio, Inc. | 394.54M | 5.53% | 621,846 | 3.32M |
| 265 | RCKT | Rocket Pharmaceuticals, Inc. | 394.19M | 1.98% | 1,322,074 | - |
| 266 | CMPX | Compass Therapeutics, Inc. | 387.19M | 8.04% | 3,827,247 | 850.00K |
| 267 | LXEO | Lexeo Therapeutics, Inc. | 377.69M | 5.71% | 1,080,262 | - |
| 268 | PALI | Palisade Bio, Inc. | 366.25M | 0.96% | 886,468 | - |
| 269 | DMAC | DiaMedica Therapeutics Inc. | 363.71M | -0.30% | 109,225 | - |
| 270 | IPSC | Century Therapeutics, Inc. | 360.71M | 5.26% | 522,583 | 109.16M |
| 271 | LYEL | Lyell Immunopharma, Inc. | 360.47M | 3.52% | 111,168 | 27.00K |
| 272 | FHTX | Foghorn Therapeutics Inc. | 360.47M | 8.98% | 280,895 | 36.74M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 354.85M | 1.30% | 343,908 | 114.70K |
| 274 | VCRE | Vicore Pharma Holding AB (publ) | 340.42M | 1.10% | - | 370.61K |
| 275 | CUVL | Clinuvel Pharmaceuticals Limited | 336.21M | -0.67% | 2,843 | 64.24M |
| 276 | FATE | Fate Therapeutics, Inc. | 326.37M | 12.45% | 4,015,590 | 6.32M |
| 277 | AGEN | Agenus Inc. | 313.34M | -7.08% | 1,190,971 | 132.69M |
| 278 | TTRX | Turn Therapeutics Inc. | 310.09M | 8.32% | 88,761 | - |
| 279 | AVXL | Anavex Life Sciences Corp. | 309.52M | 1.83% | 1,045,898 | - |
| 280 | IRD | Opus Genetics, Inc. | 304.50M | -1.61% | 915,168 | 9.86M |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 302.46M | -15.60% | 1,578,420 | 26.87M |
| 282 | VNDA | Vanda Pharmaceuticals Inc. | 302.31M | -2.34% | 1,306,671 | 215.72M |
| 283 | NMRA | Neumora Therapeutics, Inc. | 302.01M | -0.61% | 687,348 | - |
| 284 | SRZN | Surrozen, Inc. | 301.13M | 18.39% | 371,199 | 11.51M |
| 285 | FULC | Fulcrum Therapeutics, Inc. | 296.80M | 3.18% | 1,460,133 | 80.00M |
| 286 | BCYC | Bicycle Therapeutics plc | 291.87M | 5.04% | 288,700 | 61.21M |
| 287 | IMRX | Immuneering Corporation | 291.79M | 1.12% | 723,266 | - |
| 288 | ALXO | ALX Oncology Holdings Inc. | 290.38M | -0.47% | 8,493,579 | - |
| 289 | SLGL | Sol-Gel Technologies Ltd. | 287.67M | 1.27% | 46,381 | 18.47M |
| 290 | ELDN | Eledon Pharmaceuticals, Inc. | 285.25M | 6.65% | 930,126 | - |
| 291 | LCTX | Lineage Cell Therapeutics, Inc. | 278.20M | -2.65% | 833,645 | 13.08M |
| 292 | ADAG | Adagene Inc. | 271.56M | -0.72% | 285,510 | 7.67M |
| 293 | WHWK | Whitehawk Therapeutics, Inc. | 271.36M | 1.28% | 600,057 | 7.15M |
| 294 | IFRX | InflaRx N.V. | 271.02M | 6.98% | 1,167,415 | -11.54K |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 267.76M | 1.03% | 84,114 | 1.48M |
| 296 | PRQR | ProQR Therapeutics N.V. | 264.60M | -1.32% | 558,946 | 15.73M |
| 297 | MGNX | MacroGenics, Inc. | 256.80M | 0.75% | 296,658 | 157.08M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 253.89M | 2.17% | 103,916 | 32.72M |
| 299 | TRDA | Entrada Therapeutics, Inc. | 247.71M | - | 458,070 | 4.69M |
| 300 | NAGE | Niagen Bioscience, Inc. | 247.39M | 2.63% | 889,880 | 129.08M |
| 301 | CAPR | Capricor Therapeutics, Inc. | 236.86M | -2.15% | 3,618,171 | 11.13M |
| 302 | PYXS | Pyxis Oncology, Inc. | 236.32M | -0.53% | 1,242,035 | 13.86M |
| 303 | ACIU | AC Immune SA | 234.65M | 1.72% | 76,947 | 21.67M |
| 304 | TARA | Protara Therapeutics, Inc. | 231.56M | 0.49% | 340,659 | - |
| 305 | CGEN | Compugen Ltd. | 228.29M | 4.78% | 276,177 | 74.00M |
| 306 | GALT | Galectin Therapeutics Inc. | 227.21M | 7.14% | 329,875 | - |
| 307 | KROS | Keros Therapeutics, Inc. | 221.07M | 4.69% | 319,630 | 15.01M |
| 308 | CAMP | Camp4 Therapeutics Corporation | 220.17M | -5.78% | 95,152 | 3.93M |
| 309 | IVVD | Invivyd, Inc. | 218.01M | 12.29% | 3,515,932 | 55.87M |
| 310 | CNXU | Conexeu Sciences Inc. | 215.94M | -4.72% | 118,862 | - |
| 311 | ANTX | AN2 Therapeutics, Inc. | 213.58M | -2.47% | 124,475 | - |
| 312 | RNA | Atrium Therapeutics, Inc. | 211.08M | 1.90% | 103,286 | 36.68M |
| 313 | GLSI | Greenwich LifeSciences, Inc. | 210.78M | 0.84% | 88,486 | - |
| 314 | ARCT | Arcturus Therapeutics Holdings Inc. | 210.61M | 21.88% | 1,461,642 | 29.37M |
| 315 | DTIL | Precision BioSciences, Inc. | 206.74M | 0.94% | 240,109 | 45.06M |
| 316 | CLLS | Cellectis S.A. | 202.55M | 5.39% | 24,095 | 63.82M |
| 317 | NBP | NovaBridge Biosciences | 202.38M | 2.94% | 178,261 | - |
| 318 | VYGR | Voyager Therapeutics, Inc. | 201.49M | 4.47% | 469,297 | 34.46M |
| 319 | NERV | Minerva Neurosciences, Inc. | 198.93M | -3.83% | 171,167 | - |
| 320 | ACOG | Alpha Cognition Inc. | 198.80M | 5.31% | 31,058 | 10.83M |
| 321 | ALEC | Alector, Inc. | 198.75M | -2.73% | 1,247,034 | 13.86M |
| 322 | PLX | Protalix BioTherapeutics, Inc. | 198.21M | 0.82% | 670,215 | 76.38M |
| 323 | PEPG | PepGen Inc. | 197.13M | 18.26% | 3,223,998 | - |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 196.70M | 4.41% | 357,128 | - |
| 325 | CHRS | Coherus Oncology, Inc. | 196.22M | 0.40% | 1,600,234 | 50.94M |
| 326 | KRRO | Korro Bio, Inc. | 195.11M | 9.32% | 120,199 | 2.38M |
| 327 | IMUX | Immunic, Inc. | 194.79M | -1.65% | 175,602 | - |
| 328 | HUMA | Humacyte, Inc. | 193.65M | 1.21% | 2,277,638 | 2.02M |
| 329 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.77M | 3.26% | 387,929 | 17.56M |
| 330 | OTLK | Outlook Therapeutics, Inc. | 190.74M | 4.88% | 4,560,325 | 333.14K |
| 331 | MDWD | MediWound Ltd. | 184.94M | 0.77% | 58,613 | 14.48M |
| 332 | NGEN | NervGen Pharma Corp. | 181.97M | -0.58% | 278,108 | - |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 176.24M | 7.02% | 256,800 | - |
| 334 | ORMP | Oramed Pharmaceuticals Inc. | 175.98M | - | 110,557 | 2.00M |
| 335 | ARMP | Armata Pharmaceuticals, Inc. | 172.91M | 0.21% | 37,502 | 5.20M |
| 336 | NKTX | Nkarta, Inc. | 172.42M | 5.24% | 531,247 | - |
| 337 | AARD | Aardvark Therapeutics, Inc. | 172.35M | 8.22% | 74,643 | - |
| 338 | LENZ | LENZ Therapeutics, Inc. | 168.06M | 2.68% | 452,969 | 20.99M |
| 339 | OKUR | OnKure Therapeutics, Inc. | 167.65M | -0.24% | 85,009 | - |
| 340 | MIST | Milestone Pharmaceuticals Inc. | 165.98M | 3.39% | 990,172 | 1.78M |
| 341 | IPHA | Innate Pharma S.A. | 163.74M | -3.08% | 5,017 | 10.57M |
| 342 | CRBU | Caribou Biosciences, Inc. | 163.65M | 0.61% | 806,040 | 11.20M |
| 343 | YDES | YD Bio Limited | 161.38M | -2.92% | 27,709 | 510.36K |
| 344 | KZIA | Kazia Therapeutics Limited | 158.66M | 12.61% | 295,173 | 1.27M |
| 345 | CDXS | Codexis, Inc. | 158.12M | -0.68% | 764,738 | 78.09M |
| 346 | TNYA | Tenaya Therapeutics, Inc. | 157.71M | 0.14% | 1,600,385 | 1.34M |
| 347 | MENS | Jyong Biotech Ltd. | 150.69M | 0.50% | 38,871 | - |
| 348 | MOLN | Molecular Partners AG | 150.46M | 1.48% | - | 856.30K |
| 349 | NRXP | NRx Pharmaceuticals, Inc. | 150.04M | 15.86% | 5,676,502 | 2.29M |
| 350 | CNTN | Canton Strategic Holdings, Inc. | 144.22M | 0.54% | 571,842 | - |
| 351 | UNCY | Unicycive Therapeutics, Inc. | 138.88M | 0.40% | 509,095 | - |
| 352 | CNTB | Connect Biopharma Holdings Limited | 138.84M | 0.68% | 337,477 | 233.00K |
| 353 | CBUS | Cibus, Inc. | 138.16M | -3.21% | 163,622 | 4.29M |
| 354 | HURA | TuHURA Biosciences, Inc. | 135.64M | 0.71% | 66,822 | - |
| 355 | INDP | Indaptus Therapeutics, Inc. | 133.63M | -5.60% | 130,803 | - |
| 356 | EQ | Equillium, Inc. | 133.41M | -0.47% | 406,610 | 4.39M |
| 357 | PMN | ProMIS Neurosciences, Inc. | 131.91M | 10.35% | 27,673 | - |
| 358 | TLSA | Tiziana Life Sciences Ltd | 129.31M | 2.64% | 982,253 | - |
| 359 | SPRB | Spruce Biosciences, Inc. | 129.00M | 0.97% | 33,990 | 697.00K |
| 360 | VANI | Vivani Medical, Inc. | 121.59M | 3.68% | 195,688 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 120.58M | - | 351,627 | - |
| 362 | SEER | Seer, Inc. | 119.31M | -0.91% | 268,262 | 15.17M |
| 363 | GNLX | Genelux Corporation | 118.13M | -1.48% | 246,864 | 8.00K |
| 364 | ANIX | Anixa Biosciences, Inc. | 116.36M | -0.29% | 154,842 | - |
| 365 | YARW | Yarrow Bioscience, Inc. | 116.00M | -0.50% | 23,689 | - |
| 366 | NAUT | Nautilus Biotechnology, Inc. | 114.54M | 1.58% | 916,822 | 190.00K |
| 367 | CUE | Cue Biopharma, Inc. | 113.91M | 0.41% | 57,407 | 32.73M |
| 368 | COYA | Coya Therapeutics, Inc. | 112.83M | 5.02% | 141,841 | 7.94M |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 112.03M | 1.56% | 599,941 | 70.00M |
| 370 | GUTS | Fractyl Health, Inc. | 110.99M | 1.83% | 1,055,584 | 3.00K |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 108.00M | 1.40% | 202,062 | 3.17M |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 107.00M | 1.80% | 69,882 | - |
| 373 | ICCC | ImmuCell Corporation | 99.51M | -0.18% | 9,706 | 29.93M |
| 374 | PTHS | Pelthos Therapeutics Inc. | 98.57M | -3.70% | 42,086 | 27.70M |
| 375 | KLRS | Kalaris Therapeutics, Inc. | 96.83M | -2.86% | 58,833 | - |
| 376 | CGTX | Cognition Therapeutics, Inc. | 96.66M | -4.42% | 901,705 | - |
| 377 | ONCY | Oncolytics Biotech Inc. | 95.78M | 0.24% | 571,292 | - |
| 378 | ALDX | Aldeyra Therapeutics, Inc. | 93.50M | -2.52% | 1,171,283 | - |
| 379 | HRTX | Heron Therapeutics, Inc. | 92.90M | -1.64% | 2,131,206 | 150.71M |
| 380 | PYPD | PolyPid Ltd. | 92.80M | 0.62% | 144,100 | - |
| 381 | BMEA | Biomea Fusion, Inc. | 91.10M | 0.80% | 426,824 | - |
| 382 | NTHI | NeOnc Technologies Holdings, Inc. | 90.77M | - | 51,098 | 39.99K |
| 383 | FBIO | Fortress Biotech, Inc. | 88.69M | -3.61% | 579,991 | 66.16M |
| 384 | NRXS | NeurAxis, Inc. | 87.81M | 2.31% | 44,782 | 4.28M |
| 385 | VRCA | Verrica Pharmaceuticals Inc. | 87.27M | -5.22% | 126,328 | 30.32M |
| 386 | GOSS | Gossamer Bio, Inc. | 87.01M | -0.22% | 10,940,716 | 55.54M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 86.34M | - | 333,250 | - |
| 388 | RLYB | Rallybio Corporation | 85.62M | -0.19% | 12,304 | 646.00K |
| 389 | ACET | Adicet Bio, Inc. | 83.80M | 0.63% | 80,453 | - |
| 390 | ANVS | Annovis Bio, Inc. | 79.98M | 1.08% | 557,276 | - |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 79.78M | -0.85% | 11,374 | - |
| 392 | ATHE | Alterity Therapeutics Limited | 79.11M | -2.41% | 1,394 | 4.43M |
| 393 | OKYO | OKYO Pharma Limited | 78.19M | -2.93% | 105,552 | - |
| 394 | GANX | Gain Therapeutics, Inc. | 77.63M | 2.25% | 342,932 | - |
| 395 | ATRA | Atara Biotherapeutics, Inc. | 76.14M | 2.42% | 23,214 | 23.14M |
| 396 | ELTX | Elicio Therapeutics, Inc. | 74.81M | 1.59% | 122,318 | - |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 74.05M | 2.37% | 302,254 | - |
| 398 | INO | Inovio Pharmaceuticals, Inc. | 73.24M | -0.86% | 3,051,079 | 65.34K |
| 399 | SPRO | Spero Therapeutics, Inc. | 72.96M | -0.79% | 459,026 | 61.19M |
| 400 | LONA | LeonaBio, Inc. | 72.14M | -1.66% | 34,987 | - |
| 401 | CSBR | Champions Oncology, Inc. | 72.11M | - | 4,794 | 59.43M |
| 402 | CING | Cingulate Inc. | 71.92M | 5.74% | 217,440 | - |
| 403 | OSTX | OS Therapies Incorporated | 71.26M | -1.84% | 289,417 | - |
| 404 | ELOX | Eloxx Pharmaceuticals, Inc. | 70.92M | -0.79% | 32,432 | - |
| 405 | IBIO | iBio, Inc. | 70.05M | 1.44% | 436,395 | 300.00K |
| 406 | RNTX | Rein Therapeutics Inc. | 69.93M | 3.68% | 361,286 | - |
| 407 | XBIT | XBiotech Inc. | 69.21M | -0.44% | 15,353 | - |
| 408 | ALPS | Alps Group Inc | 69.07M | 0.02% | 15,614 | 3.74M |
| 409 | CRDF | Cardiff Oncology, Inc. | 67.82M | 3.28% | 639,391 | 525.00K |
| 410 | MNOV | MediciNova, Inc. | 65.96M | -1.47% | 11,385 | 596.64K |
| 411 | PLRX | Pliant Therapeutics, Inc. | 65.02M | - | 310,413 | - |
| 412 | BOLD | Boundless Bio, Inc. | 64.92M | 1.76% | 940,376 | - |
| 413 | IMA | ImageneBio, Inc. | 64.18M | 1.07% | 32,305 | 800.00K |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 63.46M | 0.85% | 118,449 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 61.55M | 2.34% | 112,963 | 11.43M |
| 416 | DWTX | Dogwood Therapeutics, Inc. | 60.70M | 3.14% | 6,746 | - |
| 417 | INMB | INmune Bio Inc. | 55.43M | 9.16% | 953,028 | 50.00K |
| 418 | XLO | Xilio Therapeutics, Inc. | 54.86M | -1.08% | 11,519 | 53.48M |
| 419 | INKT | MiNK Therapeutics, Inc. | 54.55M | -0.45% | 4,730 | - |
| 420 | TCRX | TScan Therapeutics, Inc. | 52.03M | 4.32% | 336,331 | 9.14M |
| 421 | EDSA | Edesa Biotech, Inc. | 50.77M | 4.36% | 54,688 | - |
| 422 | RNXT | RenovoRx, Inc. | 50.51M | -2.61% | 317,826 | 1.49M |
| 423 | TIL | Instil Bio, Inc. | 50.25M | 1.79% | 11,775 | - |
| 424 | VRXA | Veraxa Biotech AG | 50.18M | 6.99% | 155,794 | - |
| 425 | ATYR | aTyr Pharma, Inc. | 50.14M | 1.87% | 369,834 | 190.00K |
| 426 | IMMP | Immutep Limited | 49.96M | 2.85% | 66,444 | 5.28M |
| 427 | FLNA | Filana Therapeutics, Inc. | 48.07M | 3.75% | 614,765 | - |
| 428 | KPTI | Karyopharm Therapeutics Inc. | 48.05M | 8.72% | 1,792,751 | 151.12M |
| 429 | MREO | Mereo BioPharma Group plc | 47.29M | -3.14% | 394,255 | 500.00K |
| 430 | MCRB | Seres Therapeutics, Inc. | 47.16M | 1.04% | 62,321 | 1.88M |
| 431 | IBO | Impact BioMedical Inc. | 46.91M | -3.48% | 9,360 | 35.00K |
| 432 | EXOZ | eXoZymes, Inc. | 46.51M | -1.26% | 2,938 | -700.00 |
| 433 | MGX | Metagenomi Therapeutics, Inc. | 46.31M | -0.81% | 142,972 | 22.33M |
| 434 | GRCE | Grace Therapeutics, Inc. | 44.81M | 0.47% | 120,378 | - |
| 435 | CNTX | Context Therapeutics Inc. | 44.47M | -3.97% | 2,427,163 | - |
| 436 | PDSB | PDS Biotechnology Corporation | 43.27M | 3.77% | 225,995 | - |
| 437 | HYPD | Hyperion DeFi, Inc. | 40.93M | 1.12% | 114,409 | 1.04M |
| 438 | CRVO | CervoMed Inc. | 38.82M | 3.99% | 194,394 | 331.30K |
| 439 | NTRB | Nutriband Inc. | 37.81M | 6.69% | 6,455 | 1.80M |
| 440 | VERU | Veru Inc. | 37.40M | 0.87% | 258,996 | 16.89M |
| 441 | APLM | Apollomics, Inc. | 37.11M | -0.59% | 7,416 | 8.84M |
| 442 | RADX | Radiopharm Theranostics Limited | 36.76M | 0.36% | 51,101 | 10.86M |
| 443 | LTRN | Lantern Pharma Inc. | 36.49M | 2.88% | 61,216 | - |
| 444 | DYAI | Dyadic International, Inc. | 36.44M | -1.96% | 88,989 | 3.81M |
| 445 | SER | Serina Therapeutics, Inc. | 35.99M | 2.13% | 26,589 | 130.00K |
| 446 | BYSI | BeyondSpring Inc. | 35.77M | - | 187,704 | 1.88M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 34.59M | 1.45% | 335,799 | 31.52M |
| 448 | ENLV | Enlivex Ltd. | 33.43M | 5.05% | 202,031 | - |
| 449 | NNVC | NanoViricides, Inc. | 32.35M | 1.43% | 126,866 | - |
| 450 | BCTX | BriaCell Therapeutics Corp. | 31.65M | 5.51% | 153,583 | - |
| 451 | ESLA | Estrella Immunopharma, Inc. | 31.09M | -3.13% | 5,609 | - |
| 452 | LITS | Lite Strategy, Inc. | 30.88M | -2.31% | 167,162 | - |
| 453 | GNTA | Genenta Science S.p.A. | 30.67M | -0.76% | 53,976 | - |
| 454 | CVM | CEL-SCI Corporation | 30.06M | 6.83% | 249,464 | - |
| 455 | QNCX | Quince Therapeutics, Inc. | 29.53M | 2.23% | 30,356 | - |
| 456 | KYNB | Kyntra Bio, Inc. | 29.43M | 4.15% | 5,203 | 7.44M |
| 457 | TVGN | Tevogen Inc. | 27.30M | -0.15% | 10,822 | - |
| 458 | ACTU | Actuate Therapeutics, Inc. | 26.44M | -10.16% | 203,571 | - |
| 459 | EVAX | Evaxion A/S | 25.85M | 3.51% | 7,962 | 7.53M |
| 460 | ABVC | ABVC BioPharma, Inc. | 25.78M | - | 65,905 | 797.92K |
| 461 | IGC | IGC Pharma, Inc. | 25.68M | 2.68% | 460,733 | 1.11M |
| 462 | ATNM | Actinium Pharmaceuticals, Inc. | 25.02M | 1.32% | 133,318 | 35.09M |
| 463 | BRNS | Barinthus Biotherapeutics plc | 24.47M | 6.02% | 34,881 | 14.97M |
| 464 | LGVN | Longeveron Inc. | 24.20M | -0.97% | 417,747 | 1.22M |
| 465 | ALLR | Allarity Therapeutics, Inc. | 22.12M | -0.71% | 50,842 | 345.00K |
| 466 | QNTM | Quantum BioPharma Ltd. | 22.08M | 6.81% | 181,982 | - |
| 467 | PLRZ | Polyrizon Ltd. | 21.69M | 0.87% | 11,699 | - |
| 468 | NXTC | NextCure, Inc. | 21.09M | 4.47% | 316,114 | - |
| 469 | DARE | Daré Bioscience, Inc. | 20.97M | 5.26% | 91,805 | 1.16M |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 20.65M | -2.05% | 9,553 | -13.27K |
| 471 | CLRB | Cellectar Biosciences, Inc. | 20.54M | 1.98% | 16,081 | - |
| 472 | COCP | Cocrystal Pharma, Inc. | 20.42M | 2.91% | 54,208 | 225.00K |
| 473 | ATOS | Atossa Therapeutics, Inc. | 20.32M | -2.48% | 78,021 | - |
| 474 | CELU | Celularity Inc. | 20.28M | 2.59% | 18,068 | 26.55M |
| 475 | JSPR | Jasper Therapeutics, Inc. | 19.86M | 9.81% | 760,645 | - |
| 476 | PLUR | Pluri Inc. | 19.64M | 0.55% | 2,439 | 1.08M |
| 477 | GRDX | GridAI Technologies Corp. | 19.40M | -4.86% | 37,972 | - |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 19.30M | -1.42% | 391,142 | 21.00M |
| 479 | CTXR | Citius Pharmaceuticals, Inc. | 18.73M | 6.28% | 442,461 | 5.61M |
| 480 | MRKR | Marker Therapeutics, Inc. | 18.67M | - | 40,088 | 3.55M |
| 481 | SKYE | Skye Bioscience, Inc. | 18.25M | 10.11% | 335,343 | - |
| 482 | NCEL | NewcelX Ltd. | 17.82M | -0.90% | 4,456 | - |
| 483 | NRSN | NeuroSense Therapeutics Ltd. | 17.67M | -0.62% | 97,616 | - |
| 484 | LPCN | Lipocine Inc. | 17.56M | - | 33,856 | 1.57M |
| 485 | TVRD | Tvardi Therapeutics, Inc. | 17.54M | 1.08% | 103,873 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 16.93M | 14.22% | 376,037 | - |
| 487 | OSRH | OSR Health, Inc. | 15.55M | 1.56% | 167,249 | 2.63M |
| 488 | HIND | Vyome Holdings, Inc. | 15.16M | 0.93% | 15,216 | 152.72K |
| 489 | CYCN | Cyclerion Therapeutics, Inc. | 15.14M | 0.28% | 19,844 | 1.90M |
| 490 | MLEC | Moolec Science SA | 14.96M | 5.43% | 1,571 | 7.83M |
| 491 | TPST | Tempest Therapeutics, Inc. | 14.65M | 1.58% | 87,487 | - |
| 492 | PASG | Passage Bio, Inc. | 14.11M | - | 6,833 | - |
| 493 | PTN | Palatin Technologies, Inc. | 14.02M | -1.27% | 18,280 | 12.88M |
| 494 | KALA | KALA BIO, Inc. | 13.90M | 1.49% | 43,148 | - |
| 495 | CMMB | Chemomab Therapeutics Ltd. | 13.90M | 7.22% | 137,595 | - |
| 496 | PBM | Psyence Biomedical Ltd. | 13.24M | -0.57% | 61,814 | - |
| 497 | ICU | SeaStar Medical Holding Corporation | 13.19M | 7.54% | 62,489 | 1.44M |
| 498 | BLRX | BioLineRx Ltd. | 13.11M | -2.87% | 6,692 | 1.40M |
| 499 | AKTX | Akari Therapeutics, Plc | 12.25M | -13.37% | 68,966 | - |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 12.08M | -1.89% | 86,066 | - |